Cambridge, UK, 16th January 2023

PredictImmune are pleased to announce that they will be presenting a poster entitled “The PRECIOUS Study: a prospective, observational study of a cd8+ biomarker based prognostic test in North American IBD patients” at the Crohn’s & Colitis Congress this year. 

Please join us in the poster area on 19th and 20th January, where Dr Karen Hills, Executive Director, Medical Affairs & Market Access, will be joined by members of the PRECIOUS study team. 

Session Details:  Crohn’s & Colitis Congress 2023, Denver, Colorado.

“Omics for Prognosis, Therapeutic Selection and Mechanisms Session”
Exhibit/Poster Hall

Thursday, Jan. 19, 2023, 7:15 – 8:30 p.m. MST (UTC -7)
Friday, Jan. 20, 2023, 3:50 – 4:20 p.m. MST (UTC -7)

If you’re attending the Congress virtually, PredictImmune’s poster can be accessed online on the Congress site.